FDA approves first injectable PrEP medication to lower HIV risk
The US Food and Drug Administration has approved the first injectable medication for pre-exposure prophylaxis (PrEP) to lower the risk of getting HIV through sex, it announced Monday. Apretude is approved for adults and teens who are at risk of getting HIV through sex and who weigh at least 77 pounds. It's given first as two shots a month apart, and every two months afterward. PrEP was previously available only in the form of pills, Truvada and Descovy.
Physician Referrals Made Easy
The referral forms are available on our website, here. These referral forms can be signed by the referring physician and faxed to our pharmacy.
How NTIC Staff & Technicians Help
Our mission is to create the leading regional Infusion Medicine services throughout the North Texas area, in addition to providing a service to local physicians who prescribe infusion therapy to their patients. We provide a full spectrum of infusion therapy services. Our services range from antibiotic therapy and fertility infusions to complex specialty and biologic therapy.
How infusion therapy works
Our mission is to create the leading regional Infusion Medicine services throughout the North Texas area, in addition to providing a service to local physicians who prescribe infusion therapy to their patients. We provide a full spectrum of infusion therapy services. Our services range from antibiotic therapy and fertility infusions to complex specialty and biologic therapy.
